Anaemia is a shortage of red blood cells and haemoglobin. If you have anaemia, doctors say that you are anaemic.

Similar documents
What is an ultrasound scan?

Anaemia Patient information

Large granular lymphocytic leukaemia (LGLL)

Red blood cell transfusion

A treatment to fit your needs

ANEMIA OF CHRONIC KIDNEY DISEASE

GAZYVA for Chronic Lymphocytic Leukemia (CLL)

Autoimmune Liver Disease

Neutropenia. Freephone helpline

Pentostatin (Nipent )

The treatment is given every 3 weeks for 6 to 8 cycles.

Nivolumab. Other Names: Opdivo. About this Drug. Possible Side Effects (More Common) Warnings and Precautions

AL amyloidosis and fatigue

Blood Transfusion. There are three types of blood cells: Red blood cells. White blood cells. Platelets.

What You Need to Know About Blood Transfusion. Elianna Saidenberg May 2014

Haematology. R - CEPP Chemotherapy

Chronic lymphocytic leukaemia (CLL) and small lymphocytic lymphoma (SLL)

Obinutuzumab (lymphoma) Obinutuzumab (lymphoma)

Haematology. C = Cyclophosphamide (pronounced sigh clo fos fa mide)

Your Chemotherapy. The Common side effects are:

Capecitabine. Other Names: Xeloda. About This Drug. Possible Side Effects. Warnings and Precautions

Getting started with PROMACTA (eltrombopag)

INTRAVENOUS IRON THERAPY

Immune Thrombocytopenic Purpura (ITP)

YOUR CABOMETYX HANDBOOK

All medicines have risks and benefits. Your doctor has weighed the risks of you being given Mabthera SC against the benefits expected for you.

YOUR GUIDE TO TECENTRIQ (atezolizumab) non-small cell lung cancer (NSCLC)

Patient Education Kidney Early Education Program (KEEP) Chapter 2 bjectives: Overview 1. Understand what kidneys do. 2. Understand symptoms

Capecitabine (Xeloda )

Gemcitabine and carboplatin (Breast)

Low dose cytarabine (Low dose Ara C) Cancer Services Information for patients

Understanding Your Hemodialysis Access Options UNDERSTANDING IRON AND CHRONIC KIDNEY DISEASE

Bendamustine. Bendamustine. Your treatment Your doctor or nurse clinician has prescribed a course of treatment with bendamustine.

Traztuzumab (Herceptin)

Trastuzumab (Herceptin )

Gemcitabine and Cisplatin (urology)

A Patient s Guide to Blood Components and Products

MACE. Etoposide via an infusion (drip) over 1 hour, once a day for 5 days

ChIVPP. ChIVPP. Day 1 to 14 Chlorambucil tablets Procarbazine capsules Prednisolone tablets

VIDE. Vincristine given via intravenous (IV) infusion over 10 minutes Etoposide & doxorubicin given together via IV infusion over 4 hours

Drug information. Sarilumab SARILUMAB. is used to treat rheumatoid arthritis. Helpline

Get on with life, we ll see you. in 6 months. Living your life your way with MS

Watch and Wait. A Guide for Patients

Gemcitabine and carboplatin (Lung)

Maternity Services Intravenous iron therapy Information for women

Cisplatin and gemcitabine (GI)

MEDICATION GUIDE. Epogen (Ee-po-jen) (epoetin alfa)

Hospital No. Weston Park Hospital contact number

Chronic Kidney Disease (CKD) stages 3b to 5 Overview

GCVP. Cyclophosphamide by injection Vincristine by short infusion. Gemcitabine by infusion over 30 minutes

VDC IE. Your treatment You will have 14 cycles of VDC IE given every 2 to 3 weeks.

What You Need to Know About LEMTRADA (alemtuzumab) Treatment: A Patient Guide

Vinblastine (Lymphoma)

Peripheral neuropathy

X-Plain Blood Transfusion Reference Summary

Anaemia. The symptoms of anaemia are tiredness, shortness of breath and being pale. The anaemia in CDA is very variable.

Technology appraisal guidance Published: 26 November 2014 nice.org.uk/guidance/ta323

Personal Calendar Tracker

Methotrexate for inflammatory bowel disease: what you need to know

A practical guide to understanding cancer

Watch and Wait. A Guide for Patients

What Your Kidneys Do and What Happens When They Fail

Myeloma Haematology and Transplant Unit MPT

Bevacizumab (Avastin ) treatment for Neurofibromatosis Type 2 (NF2) Information for patients

Hepatitis A. Fighting liver disease

Two further publications by Leukaemia Research are available should you require further information about the transplant procedure itself:

TREPROSTINIL INJECTION

SMC briefing note. About SMC. cetuximab (Erbitux ) Scottish Medicines Consortium advice to NHSScotland. Number 27 February 2010

Autoimmune lymphoproliferative syndrome (ALPS)

QUESTIONS TO ASK MY DOCTOR

Fuel your determination to live longer with KYPROLIS. Look inside to learn more.

READY. SET. DOPTELET. HELP GET READY FOR YOUR UPCOMING PROCEDURE

For the Patient: USMAVFIPI

NUCALA. mepolizumab. Patient Support

Etoposide Cisplatin / Etoposide, Methotrexate, Actinomycin

Capecitabine chemotherapy and concurrent radiotherapy to the pancreas

Understanding bone metastases and XGEVA

Myocet. Myocet. Myocet is given into the vein (intravenously) through a fine tube (cannula) as an infusion over 1 hour.

Anaemia & Cancer. John de Vos Consultant Haematologist RSCH

BLOOD DONATION Northern Ireland Blood Tranfusion Service

INTRODUCTION TO HAEMODIALYSIS

Vincristine by short infusion Doxorubicin by injection Cyclophosphamide by injection Rituximab by an infusion over between 60 minutes to a few hours

Nivolumab. Nivolumab

Myeloma Haematology and Transplant Unit CTD1

Low dose Cytarabine for Acute Myeloid Leukaemia (AML)

Paclitaxel (Taxol) and carboplatin

Your CODOX-M / IVAC treatment. Information for patients Specialised Medicine

Methotrexate. About This Drug. Possible Side Effects. Warnings and Precautions

Weekly standard dose. Paclitaxel (Taxol) and carboplatin

Tamoxifen Tamoxifen. Your treatment Your doctor or nurse clinician has prescribed for you a treatment which includes the hormonal therapy tamoxifen.

Dexamethasone is used to treat cancer. This drug can be given in the vein (IV), by mouth, or as an eye drop.

Abemaciclib (Verzenios ) Abemaciclib (Verzenios )

Teriparatide (also known as Forsteo) Rheumatology Department Patient Information Leaflet

Surgery to remove the spleen (elective splenectomy)

PATIENT AGREEMENT TO SYSTEMIC ANTI- CANCER THERAPY:

Bowel health and screening: carers guide. A booklet for carers of people who use easy read materials

Plasma exchange. Information for patients Sheffield Kidney Institute (Renal Unit)

Gemcitabine (Gemzar )

STEP BY STEP. Aplastic Anaemia

Blood Conservation. To introduce the learner to the basic concepts of blood conservation!! Learning Outcomes

Transcription:

Freephone helpline 0808 808 5555 information@lymphoma-action.org.uk www.lymphoma-action.org.uk Anaemia Anaemia means that there is too little haemoglobin (the chemical that carries oxygen) and too few red cells (that carry haemoglobin) in the blood. Many people with lymphoma are affected by anaemia at some point during their illness, either because of the lymphoma itself or as a side effect of the treatment they are having. Anaemia can make people feel tired or short of breath. On this page What is anaemia? How much haemoglobin should you have? Why is haemoglobin important? What causes anaemia? What are the symptoms? How is it treated? What is anaemia? Anaemia is a shortage of red blood cells and haemoglobin. If you have anaemia, doctors say that you are anaemic. Haemoglobin is a protein found in red blood cells. It carries oxygen from the lungs to the rest of the body. Red blood cells are made in the bone marrow (the spongy centre of some bones). They normally work for about 3 months

before they wear out and are removed from the blood. The bone marrow is working all the time to make new red blood cells. How much haemoglobin should you have? The amount of haemoglobin (and the number of red cells) in your blood is measured by a test called the full blood count (FBC). Doctors talk about a range of normal results because some people naturally have higher or lower levels than do others. Men usually have more haemoglobin than women, so there are different ranges for men and women. Different hospitals use slightly different ranges. A normal haemoglobin level is roughly: above 135 grams per litre of blood (g/l) for a man, and above 115 g/l for a woman. These values used to be given as 13.5 g/dl and 11.5 g/dl (grams of haemoglobin per 100 millilitres of blood, instead of per litre). The number of red blood cells and the amount of haemoglobin go up and down together. Doctors don t usually mention the number of red blood cells when talking about anaemia. Why is haemoglobin important? Red blood cells contain haemoglobin, which is the protein that carries oxygen around the body. It is important that all organs and tissues of the body get enough oxygen; they cannot work properly without it. When red blood cells pass in the bloodstream through the lungs, the haemoglobin picks up oxygen. These red blood cells then pass in the bloodstream around the rest of the body. As they do so, the haemoglobin releases its oxygen to the organs that need it. If there are fewer red blood cells in the bloodstream, there is less haemoglobin. This means that less oxygen can be carried around the body to

the organs that need it. What causes anaemia in people with lymphoma? Possible causes of anaemia in people with lymphoma are: lymphoma in the bone marrow a side effect of treatment red blood cells being destroyed by an antibody that attacks them (this is known as 'autoimmune haemolytic anaemia ) other causes, some related to the lymphoma and its treatment, and other having nothing to do with the lymphoma. Lymphoma in the bone marrow If lymphoma cells are in the bone marrow, they take up space that is normally used to make healthy blood cells. This can lower the number of red blood cells your bone marrow makes, meaning you have less haemoglobin and become anaemic. Anaemia caused by lymphoma in the bone marrow usually comes on slowly. It is seen more often in people with low-grade lymphomas but some highgrade lymphomas can affect the bone marrow too. Anaemia caused by lymphoma in the bone marrow often starts to improve once treatment for the lymphoma has started to work. A side effect of treatment Although the aim of treatment is to kill the lymphoma cells, a side effect of many types of chemotherapy, and some radiotherapy treatments (eg radiotherapy to the pelvis), is that some healthy cells are also destroyed. This may include blood cells that are developing in the bone marrow. If chemotherapy stops new red blood cells being made, it usually doesn t cause anaemia straightaway. Red blood cells live for 3 months, so there are

still many older cells around when treatment starts. As the treatment goes on, the older cells start to wear out and be removed, while fewer new cells are being made. This means there is less haemoglobin in the blood and anaemia can start to be a problem. How much of a problem it becomes depends on: how strong your chemotherapy is whether you had lymphoma in the bone marrow before you started treatment whether you have additional problems, eg infection. Radiotherapy doesn t usually affect enough of the bone marrow to cause anaemia. Autoimmune haemolytic anaemia Sometimes the body s immune system starts to make antibodies against cells of the body. These antibodies are known as autoantibodies. If the autoantibodies stick to red blood cells, the cells are removed as they pass through the spleen. If the bone marrow can t make new red cells fast enough to replace the ones lost, anaemia develops. This type of anaemia is known as autoimmune haemolytic anaemia (AIHA). It happens more often in people with low-grade lymphomas, such as chronic lymphocytic leukaemia (CLL). Other causes Other ways that lymphoma and its treatment can cause anaemia include: bleeding, which might happen if you have lymphoma in the bowel, or if you have low platelets (thrombocytopenia) lack of certain vitamins, which may happen if you are not eating well anaemia of chronic disease, which is when the bone marrow makes new cells more slowly because of an infection or an inflammation that s been in the body for a long time.

What are the symptoms of anaemia? Many people with a haemoglobin level below normal do not notice anything different. This is because the body has a built-in reserve with much more haemoglobin than is needed for day-to-day life. If your haemoglobin is only slightly low, you can tolerate your anaemia. As the amount of haemoglobin falls, the organs of the body receive less oxygen. Symptoms start to occur if parts of the body reach a point of not getting enough oxygen. This is when you stop tolerating your anaemia. Symptoms of anaemia include: fatigue (extreme tiredness) feeling weak and lethargic (lacking energy) feeling short of breath when doing things feeling your heart fluttering or pounding (palpitations) feeling dizzy or faint headache or sometimes aching bones. If you have anaemia, your complexion might look paler than is normal for you. People vary in how much anaemia they can tolerate. How you feel depends on: your age your fitness whether or not you have any other conditions, such as heart disease. Having lymphoma means you might notice symptoms of milder anaemia (less of a fall in your haemoglobin) than you would have done otherwise. The draining effects of having lymphoma and its treatment can make you less able to tolerate your anaemia. Also, if you get an infection or fever, your anaemia could worsen and you might feel the effects of it more.

Let your medical team know if you notice any of the symptoms. They are likely to suggest you have a blood test to check your haemoglobin level. Many of these symptoms can also be caused by problems other than anaemia. If your symptoms are due to anaemia, your doctor should talk to you about possible treatments. How is anaemia treated? Treatment for anaemia depends on its cause often there is more than one. Your doctor is likely to first ask for other blood tests to find the reason for your low haemoglobin. Sometimes the cause is easy to treat and has nothing to do with your lymphoma. For example, if your anaemia is caused by low iron, you might need a tablet to supplement your diet. Always check with your medical team before taking any medicines or supplements that haven t been prescribed for you. An iron infusion can sometimes be needed. Your doctor will tell you if this is the case. If your anaemia is caused by loss of blood, you may have other tests to look for the source of the bleeding. If your anaemia is caused by your bone marrow not making enough red blood cells, you ll need treatment. You might be given a blood transfusion or erythropoietin (EPO) injections to boost your bone marrow. These treatments don t work well for autoimmune haemolytic anaemia. Instead, treatment for autoimmune haemolytic anaemia aims to lower the levels of the autoantibody. Blood transfusion If your anaemia is causing you serious symptoms, your doctor may talk to you about having a blood transfusion. In a blood transfusion, you are given enough blood to ease your symptoms your haemoglobin may still not be back to its normal level. Sometimes 2 or 3 units (roughly a pint of blood each) are given at a time. Transfusion can take much of the day to complete. Usually a transfusion will make you feel better for a few weeks. Afterwards, if your bone marrow still isn t working well, you may begin to get symptoms

again. This is because, just like your own cells, the transfused red cells are removed from your blood as they age. Erythropoietin (EPO) Erythropoietin (EPO) is a hormone (a chemical messenger) that occurs naturally in your body. It is made by the kidneys and tells the bone marrow to make more red blood cells. It can also be made as a medicine that is given as a subcutaneous injection (an injection into the fatty tissue just under the skin). EPO is sometimes given to people with cancer who are being treated with chemotherapy and have symptoms of anaemia. Trials have shown it often improves the anaemia. As a result, fewer blood transfusions are needed and people s quality of life is better. EPO is not suitable for everyone because of side effects, which include: raised blood pressure (hypertension) an increased risk of blood clots. Other side effects include: itching nausea and/or diarrhoea pain and/or redness at the injection site headache oedema (swelling of tissues due to a build up of fluid). The National Institute for Health and Care Excellence (NICE) recently updated its guidance on using EPO for people with cancer. EPO is now recommended as a possible treatment for anaemia in people having chemotherapy to treat cancer. If your doctors think you should consider this treatment, they will talk to you more about the potential benefits and risks. Treatments for autoimmune haemolytic anaemia

If your anaemia is due to autoantibodies destroying your red cells, blood transfusions usually do not help. Instead, the treatment of this type of anaemia aims to reduce the number of autoantibodies being made. This is usually done, at least at first, by giving you treatment with steroids, often prednisolone. The dose of steroid is high to begin with, which may cause irritation to your stomach. You may be given another drug to protect your stomach. Once your red cells are no longer being destroyed, the dose of steroid is lowered. Treating your lymphoma may also help to stop the autoantibodies being made. Rituximab(MabThera ), with or without chemotherapy, tends to reduce the number of autoantibodies as well as kill the lymphoma cells. References These are a few of the sources we used to prepare this information. The full list of sources is available on request. Please contact us by email at publications@lymphoma-action.org.uk or phone on 01296 619409 if you would like a copy. Norfolk D (ed). Handbook of Transfusion Medicine. 5th edition. 2013. The Stationery Office, Norwich. Watkins T, et al. Transfusion indications for patients with cancer. Cancer Control, 2015. 22: 38 46. Bohlius J, et al. Effects of erythropoiesis-stimulating agents on fatigue- and anaemia-related symptoms in cancer patients: systematic review and meta-analyses of published and unpublished data. British Journal of Cancer, 2014. 111: 33 45. National Institute for Health and Care Excellence. 2014. Erythropoiesisstimulating agents (epoetin and darbepoetin) for treating anaemia in people with cancer having chemotherapy. Available at: www.nice.org.uk/guidance/ta323 (accessed November 2015). Ohashi Y, et al. Meta-analysis of epoetin beta and darbepoetin alfa treatment for chemotherapy-induced anemia and mortality: Individual

patient data from Japanese randomized, placebo-controlled trials. Cancer Science, 2013. 104: 481 485. Tonia T, et al. Erythropoietin or darbepoetin for patients with cancer (Review). Cochrane Database of Systematic Reviews, 2012. 12: CD003407. Further reading Glossary Treatment for low blood counts Your medical team Thrombocytopenia

Acknowledgements We would like to thank the Expert Reviewers and members of our Reader Panel who gave their time to review this information. Content last reviewed: February 2016 Updated: April 2018 Next planned review: February 2019 Lymphoma Action Tell us what you think and help us to improve our resources for people affected by lymphoma. If you have any feedback, please visit www.lymphoma-action.org.uk/feedback or email publications@lymphomaaction.org.uk. All our information is available without charge. If you have found it useful and would like to make a donation to support our work you can do so on our website www.lymphoma-action.org.uk/donate. Our information could not be produced without support from people like you. Thank you. Disclaimer We make every effort to make sure that the information we provide is accurate at time of publication, but medical research is constantly changing. Our information is not a substitute for individual medical advice from a trained clinician. If you are concerned about your health, consult your doctor. Lymphoma Action cannot accept liability for any loss or damage resulting from any inaccuracy in this information or third party information we refer to, including that on third party websites. The following user-generated information is excluded from our Information Standard certification: web blogs, chatrooms, forums, personal experience pages, social media, fundraising materials and Lymphoma Matters magazine. Neither the Information Standard scheme operator nor the scheme owner shall have any responsibility whatsoever for costs, losses or direct or indirect damages or costs arising from inaccuracy of information or omissions in the information published on the website on behalf of Lymphoma Action.